Please try another search
For the fiscal year ended 31 December 2020,Biosearch SA revenues increased 13% to EUR25.8M. Net incomeincreased from EUR507K to EUR1.5M. Revenues reflect ProductSales segment increase of 15% to EUR25.3M, Other Countriessegment increase of 44% to EUR7.9M, Other European Unionsegment increase of 4% to EUR12.8M. Net income benefitedfrom Social Expense decrease of 8% to EUR1.4M (expense).
Period Ending: | Dec 31, 2020 | Jun 30, 2020 | Dec 31, 2019 | Jun 30, 2019 |
---|---|---|---|---|
Total Revenue | 11.57 | 14.27 | 11.47 | 11.34 |
Gross Profit | 7.37 | 8.51 | 6.83 | 7.73 |
Operating Income | 0.7 | 1.22 | 0.55 | 0.27 |
Net Income | 0.49 | 1.05 | 0.33 | 0.17 |
Period Ending: | Dec 31, 2020 | Jun 30, 2020 | Dec 31, 2019 | Jun 30, 2019 |
---|---|---|---|---|
Total Assets | 34.71 | 35.58 | 33.13 | 33.23 |
Total Liabilities | 9.54 | 10.69 | 9.6 | 9.84 |
Total Equity | 25.17 | 24.89 | 23.54 | 23.39 |
Period Ending: | Dec 31, 2020 | Jun 30, 2020 | Dec 31, 2019 | Jun 30, 2019 |
---|---|---|---|---|
Period Length: | 12 Months | 6 Months | 12 Months | 6 Months |
Cash From Operating Activities | 6.34 | 4.21 | 1.25 | -0.04 |
Cash From Investing Activities | -1.58 | -0.81 | -2.6 | -0.89 |
Cash From Financing Activities | 0.13 | -0.15 | 0.65 | 0.1 |
Net Change in Cash | 4.89 | 3.26 | -0.7 | -0.82 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review